Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Fuzeon
Enfuvirtide is an antiretroviral medication used in combination with other antiretroviral agents to treat HIV-1 infection in adults and children 6 years of age and older. It belongs to the fusion inhibitor class of antiretrovirals and works by blocking the fusion of the HIV-1 virus with the host cell membrane, preventing the virus from entering the cell and replicating.
For the treatment of HIV-1 infection in combination with other antiretroviral agents.
Outcome:
Decreased enfuvirtide levels
Mechanism:
Induction of CYP3A4 enzymes
Outcome:
No clinically significant interaction
Mechanism:
Unknown
Outcome:
No clinically significant interaction
Mechanism:
Unknown
Most likely new formulation: Long-acting injectable version (2025, 70% confidence)
Based on current usage trends and emerging resistance patterns, there is a 15% likelihood of new guidelines for enfuvirtide use in combination therapy within the next 3 years.
Antiretroviral, Fusion Inhibitor
Fusion Inhibitor (peptide)